Ken Griffin Bio Xcel Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 34,500 shares of BTAI stock, worth $73,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,500

Previous 22,200 55.41%

Holding current value

$73,485

Previous $13,000 7.69%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.95 - $4.04 $68,860 - $142,664	35,313 Added 662.53%	40,643 $114,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $20,810 - $49,424	-8,970 Reduced 62.73%	5,330 $15,000
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $570 - $2,713	-229 Reduced 1.58%	14,300 $36,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $446,680 - $2 Million	-69,903 Reduced 82.79%	14,529 $96,000
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $669,431 - $1.26 Million	37,821 Added 81.14%	84,432 $1.58 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $107,450 - $235,133	-10,483 Reduced 18.36%	46,611 $1 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $147,003 - $235,020	13,137 Added 29.89%	57,094 $675,000
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $33,916 - $80,941	-3,756 Reduced 7.87%	43,957 $581,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $1,740 - $2,648	-116 Reduced 0.24%	47,713 $997,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $296,146 - $516,489	14,719 Added 44.45%	47,829 $972,000
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $1.11 Million - $1.49 Million	-46,561 Reduced 58.44%	33,110 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $258,110 - $344,888	8,882 Added 12.55%	79,671 $2.32 Million
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $29 Million - $48 Million	-743,453 Reduced 91.31%	70,789 $3.06 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $2.74 Million - $3.66 Million	64,621 Added 8.62%	814,242 $37.6 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $16.3 Million - $28.2 Million	435,659 Added 138.76%	749,621 $32.5 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $5.53 Million - $18.4 Million	313,962 New	313,962 $16.6 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

8.63M

Call Options Held

34.5K

Put Options Held

59.4K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $59.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account